A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new ...

Baby KJ Muldoon, the first patient to successfully receive personalized CRISPR gene editing therapy has returned home after ...

Gene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has ...

A research team has developed and safely delivered a personalized gene editing therapy to treat ... six months and marks the first time the technology has been successfully deployed to treat ...

The world's first patient to be treated with personalized gene editing therapy is finally headed home ... with staffers lining the hallway as baby KJ was led out. Prior treatement, KJ was dealing ...

A nine-month-old baby has become the first person ever to be successfully treated with personalized gene editing therapy. Researchers corrected a specific gene mutation in baby KJ Muldoon‘s ...

A baby in Pennsylvania has become the first recipient of an experimental genetic therapy ... their gene editing technique. Over the course of a few months, they worked to develop a personalized ...

Baby KJ was successfully treated with a customized CRISPR gene editing therapy by a team at Children's Hospital of Philadelphia and Penn Medicine in a historical medical breakthrough. Now after over ...

An attentive doctor at the University of Pennsylvania ... All this is possible because KJ is the first-ever recipient of a gene therapy designed to treat only a single person.

The process, from diagnosis to treatment, took only six months and marks the first time the technology has been successfully ... Pennsylvania (Penn) developed the customized therapy using the gene ...

researchers led by teams at Children’s Hospital of Philadelphia and University of Pennsylvania report on the first use of the gene-editing technology CRISPR in a customized therapy designed to ...

A research team supported by the National Institutes of Health (NIH) has developed and safely delivered a personalized gene editing therapy to treat ... only six months and marks the first time the ...